Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
341.7(c) 343.65(c) 347.1(c) 348.4(c) 348.25(c) Last
1 197 981 1 241 116 1 443 630 1 481 920 4 238 079 Volume
-0.09% +0.57% +1.00% +0.37% -0.04% Change
More quotes
Financials
Sales 2021 60 592 M 65 621 M 65 621 M
Net income 2021 14 513 M 15 717 M 15 717 M
Net cash position 2021 4 915 M 5 323 M 5 323 M
P/E ratio 2021 20,3x
Yield 2021 2,69%
Sales 2022 61 087 M 66 157 M 66 157 M
Net income 2022 15 397 M 16 675 M 16 675 M
Net cash position 2022 11 066 M 11 985 M 11 985 M
P/E ratio 2022 19,3x
Yield 2022 2,79%
Capitalization 301 B 326 B 325 B
EV / Sales 2021 4,88x
EV / Sales 2022 4,74x
Nbr of Employees 101 465
Free-Float 83,4%
More Financials
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The... 
Sector
Pharmaceuticals
Calendar
07/22Earnings Release
More about the company
Ratings of Roche Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about ROCHE HOLDING AG
06/18Ahead of pivotal AGM, Toshiba board chairman vows to be 'agent of positive ch..
RE
06/17ROCHE HOLDINGS AG  : Deutsche Bank reiterates its Neutral rating
MD
06/17Synlogic, Roche in Bowel-Disease Collaboration
DJ
06/17ROCHE  : Syncona CFO to Retire; Three New Executives Named
MT
06/17ROCHE  : Check You Employment Agreement's Restrictive Covenant
AQ
06/16WALL STREET STOCK EXCHANGE : How yesterday’s data could affect Fed policy
06/16Atea Pharma Hits Development Milestone for Covid-19 Treatment
DJ
06/16ROCHE  : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milest..
AQ
06/16ROCHE  : Regeneron COVID-19 Antibody Cocktail Reduces Death Risk in Late-Stage T..
MT
06/15ELOXX PHARMACEUTICALS  : Roche Discloses 5.3% Stake in Eloxx Pharmaceuticals
MT
06/15ROCHE HOLDINGS AG  : Berenberg reaffirms its Neutral rating
MD
06/15ROCHE  : to Release Further Data on Therapies Across Neuroscience Portfolio
MT
06/15PRESS RELEASE  : Roche data at EAN 2021 showcase -3-
DJ
06/15PRESS RELEASE  : Roche data at EAN 2021 showcase -2-
DJ
06/15PRESS RELEASE  : Roche data at EAN 2021 showcase significant impact of therapies..
DJ
More news
News in other languages on ROCHE HOLDING AG
06/18La FDA homologue d'urgence un test PCR Covid de Roche
06/18Roche erhält FDA-Notzulassung für PCR-Covid-Test
06/17CORONAVIRUS : les USA allouent 3l2 milliards à la recherche d'antiviraux
06/17USA investieren 3,2 Milliarden in Entwicklung antiviraler Medikamente
06/17MÄRKTE EUROPA/SMI steigt erstmals über 12.000 Punkte - Curevac schwach
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Stock Trading Strategies
ROCHE HOLDING AG - 2020
Close to an important medium term support level
BUY
More Stock Trading Analysis
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 355,40 CHF
Last Close Price 348,25 CHF
Spread / Highest target 25,8%
Spread / Average Target 2,05%
Spread / Lowest Target -16,7%
EPS Revisions
Managers and Directors
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
André S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING AG12.70%325 803
JOHNSON & JOHNSON2.92%426 557
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668